Webinar on

Peptide

Scientific Program

Keynote Session:

Meetings International -  Conference Keynote Speaker Nozer Mehta  photo

Nozer Mehta

PeptideTechnologies,LLC, USA

Title: Non-Invasive Delivery of Peptides: Advances in Oral Delivery

Biography:

Nozer Mehta Peptide Technologies, LLC, USA well recognized leader with 30 years of experience in the development of peptide-based therapeutics, and an inventor on 28 issued patents and numerous applications. Excellent communication, team building and leadership skills. Proven scientific leader for internal projects, as well as collaborative teams with several external companies across multiple therapeutic areas, including osteoporosis, osteoarthritis, obesity and diabetes. Experience with presentations at major international conferences and to pharmaceutical companies, and internally to the Board of Directors. An area of extensive preclinical and clinical development expertise is the oral delivery or peptides and certain classes of small molecule drugs. Additional areas of competency include recombinant expression technologies for peptides, novel target identification, validation, and preclinical and clinical development of peptide drugs.

Abstract:

Non-invasive peptide delivery routes such as oral, buccal, nasal, pulmonary and transdermal offer several advantages including safety and ease of use for the patient, and the potential for increased physician acceptance and patient compliance for chronic indications. Oral delivery remains the most extensively studied non-invasive route, but it presents numerous biological challenges. Of the few oral peptides currently marketed, most are intended for localized intestinal delivery or represent peptides with special characteristics. Absorption of orally delivered peptides into the systemic circulation generally occurs in the duodenum or lower regions of the small intestine. The intestinal epithelium and the mucus layer offer a barrier to the transport of molecules greater than 2 to 3 amino acids in size, and intestinal proteolytic enzymes derived either from the pancreas or from the intestinal brush border membranes rapidly cleave peptide bonds. For most peptides, these challenges of poor intestinal permeability, susceptibility to proteolytic degradation, as well as their short half-life, propensity to aggregate, and other limitations need to be overcome by formulation or peptide structure modifications to increase bioavailability and develop commercially successful products. Strategies such as cyclization, addition of unnatural amino acids, and blocking of N- and C-termini to stabilize peptides and increase their protease resistance, are examples of beneficial structural modifications. The addition of protease inhibitors and permeation enhancers to the formulation, conjugation to peptide transporters, and encapsulation in robotic pills or micro- and nano-spheres are also widely used techniques. However, further increases in bioavailability, decreases in inter- and intra-patient variability, elimination of food effects, and confirmation of long term safety of formulation excipients remain as foci for further efforts to fully realize the potential for oral delivery. A variety of peptide molecules are currently in pre-clinical or different stages of clinical development using one or more of these technologies to facilitate paracellular or transcellular transport, and recent data on these studies will be presented.

Meetings International -  Conference Keynote Speaker Nagana A. Goud photo

Nagana A. Goud

Auro Peptides, India

Title: Purification of Peptides

Biography:

Nagana A. Goud , Auro Peptides, IndiaExperienced Co-Founder with a demonstrated history of working in the pharmaceuticals industry. Skilled in Verification and Validation (V&V), Pharmaceutics, Generic Programming, Good Laboratory Practice (GLP), and Liquid Chromatography-Mass Spectrometry (LC-MS). Strong business development professional with a Post-Doctorate focused in Peptide Synthesis from University of North Carolina, Chapel Hill, NC.

Abstract:

Solid phase peptide synthesis is normally following the four stages: synthesis, global deprotection, purification and freeze-drying and isolation. Among them, the purification crude peptide is very challenging because of the following difficulties: small loading amounts, long separation time, poor recoveries and that leads to high costs. Moreover, crude synthetic peptides contain impurities with retention characteristics very similar to the target peptide which can present additional purification challenge. In addition, hydrophobic peptides can pose greater challenges when these peptides have low solubility in both aqueous and organic solvents. Although synthesis and purification of short-peptides is strait forward, the synthesis and purification of longer peptides is problematic because of poor solubility in the solvent used both in reverse-phase and normal phase chromatography. 

Meetings International -  Conference Keynote Speaker Zhou Quancheng photo

Zhou Quancheng

School of Agricultural Engineering and Food Science, China

Title: Effects of Extrusion and Enzyme Combined Extrusion on the Structure of Pea Protein

Biography:

Zhou Quancheng has his expertise in evaluation and passion in improving the health and wellbeing. His open and contextual evaluation model based on antioxidant peptide creates new pathways for improving healthcare. He has built this model after years of experience in research, evaluation, teaching and administration in  education institution. The foundation is based on Key research and development plan of shandong province (special medical food plan) (17YYSP033 2018YYSP017)

Abstract:

The aim of this paper was to explore the effect of extrusion and enzyme combined extrusion on the structure of pea protein. Pea protein was pretreated with extrusion and enzyme co-extrusion. The effect of pretreatment of extrusion on pea protein was further studied by measuring the microstructure, disulfide bond, secondary structure, functional group and amino acid composition of the optimal substrate. The results showed that the extrusion and enzyme co-extrusion could cause significant change to the microstructure of pea protein, reduce the content of disulfide bond, cause change to the content of secondary structure and the composition of amino acids, but no change to the functional group.

Meetings International -  Conference Keynote Speaker Joanna Bojarska photo

Joanna Bojarska

Zeromskiego,Poland

Title: Novel biologically important supramolecular synthons in short peptides

Biography:

Joanna Bojarska has completed his PhD (“Structure of gramicidin D ionic channels in crystals of its complexes with cesium and rubidium”) at the age of 27 years from Technical University, Poland. She is currently working at the Institute of General and Ecological Chemistry at the same University. She has published more than 35 papers in reputed journals, e-book and 100 international conference communications. Her publications reflect her research interests in small and macrosupramolecular crystallography of biomolecules. She is a member of The European Peptide Society. She is awarded by verified certificate of Harvard University (Biochemistry upper level course), Awards of the Dean of Faculty of Chemistry and the Rector of the Lodz University of Technology for outstanding achievements in science, teaching and popularization of crystallographic science.

Abstract:

Short peptides have attracted an increasing interest due to their wide applications, inter alia in anticancer therapy or supramolecular biofunctional materials [1-3]. Amino acids and peptides in living systems, whose architecture is controlled by non-covalent interactions, have a valuable input in understanding highly complex biological processes. Supramolecular interactions in precise co-operation just like virtuosos play a symphony of life. Supramolecular chemistry of biomolecules is crucial in interpretation of biological phenomena. Design of smart bio-materials or drugs should be based on the knowledge of weak interactions at molecular and higher topological level. Nevertheless, the detailed knowledge on this subject is still challenging. The concept of supramolecular synthons, recurring patterns of inter-contacts between functional groups, is useful in small supramolecules and in understanding of the interplay of biocomplexes (ligand–protein cocrystals, between different scaffolds in the ligand molecules and the main/side chain of proteins in the active sites). This e-poster focuses on synthesis and supramolecular crystallography of linear and cyclic short peptides, supported by theoretical methods, taking a holistic look at their landscape in the context of subtle supramolecular effects on the basis of our own research and those form the databases (CSD/PDB). The aim is to present the potential uses of supramolecular synthon idea, which evolves in various fields in an intriguing manner, in relation to short peptides. Novel biologically important synthons, e.g. created by weak πcyclopropyl (vide Image) or Fmoc-synthons, will be discussed in detail. We hope that our study will contribute to the development of supramolecular chemistry of peptides and also in protein recognition or development of advanced therapeutic approaches.

Meetings International -  Conference Keynote Speaker Sinazo Cobongela, photo

Sinazo Cobongela,

Nanotechnology Innovation Centre, Randburg, South Africa

Title: :Design and synthesis of cyclic Acyldepsipeptide analogues with increased antimicrobial activity

Biography:

Sinazo Cobongela obtained her Masters at the age of 23 years from the University of KwaZulu Natal and currently doing her PhD at the school of Chemistry, University of Witwatersrand, South Africa. She is a Scientist at the Departments of Science and Innovation/Mintek Nanotechnology Innovation Centre (NIC), Randburg, South Africa. She is in charge of MinNanoGold® and MinPeptides® under the Biolabels unit at NIC.

Abstract:

Over 480 000 cases of multidrug-resistant (MDR) tuberculosis (TB) occur every year globally, 9% of them being affected by extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis [1]. The treatment of MDR/XDR-TB is unfortunately long, toxic and expensive, and the success rate largely unsatisfactory. The emerging resistance of most pathogens to currently available antibiotics is raising an urgent need for new and effective antibiotic drugs. Over the years, peptides have been promising therapeutic agents for various diseases like cancer, cardiovascular, diabetes and others. There is an escalating attention towards synthetic analogues of natural antimicrobial peptides (AMPs) as potential effective antibiotics with novel mechanism to combat the bacterial resistance problem. Recent findings show a promising future for AMPs as active drug against multidrug resistant bacteria [2].Chemistry and biology of peptides have seen a renaissance in this century as many of the peptide-based therapeutics have entered the market and many more are in the different phases of clinical trials [3]. This study will focus on the synthesis of novel antimicrobial peptides and/or peptidomimetics ADEP A54556 factor A analogues and these will be tested for their antibacterial and anti-mycobacterial activity using different bacterial strains. Toxicity of the peptide analogues will be determined by the MTS cell viability colorimetric assay and xCELLigence. Wound healing properties of the analogues will be determined by scratch assay using different skin cells.

Meetings International -  Conference Keynote Speaker El Hadji Seydou Mbaye photo

El Hadji Seydou Mbaye

Cancer Institute, Aristide Le Dantec Hospital, Dakar, Senegal

Title: Human Papillomavirus Infection in genital Women in four regions of Senegal

Biography:

El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France).

Abstract:

INTRODUCTION:

Cervical cancer is the most frequent cancer among women in Senegal. However, there are few data concerning the HPV types inducing neoplasia and cervical cancers and their prevalence, in the general population of Senegal

AIMS:

The aim of this study is to determine the prevalence of HPV infection in Senegalese women aged from 18 years and older.

MATERIALS AND METHODS:

A study was performed on 498 cervix samples collected from healthy women aged 18 and older in Dakar. 438 other samples were collected from three other regions, Thiès, Saint Louis and Louga. The samples were screened for 21 HPV genotypes using an HPV type-specific E7 PCR bead-based multiplex genotyping assay (TS-MPG) which is a laboratory-developed method for the detection of HPV.

RESULTS:

The prevalence for pHR/HR-HPV in the region of Dakar was 20.68%. HPV 52 (3.21%) was the most prevalent HPV type, followed by HPV 16 (3.01%) and HPV 31 (3.01%). In the regions of Thiès, Louga and Saint Louis, the prevalence for pHR/HR-HPV was 29.19%, 23.15% and 20%, respectively

CONCLUSION:

The study revealed the specificity of the HR-HPV prevalence in Dakar and other regions of Senegal. The patterns differs from the one observed in the other regions of the world and rise the issue of the development of vaccination program in the country. Such a program should take into account the real HPV prevalence for an effective protection of HPV-associated diseases.

 

Oral Session 1:

  • Oral Session
Meetings International -  Conference Keynote Speaker Kuddus M photo

Kuddus M

University of Hail, Saudi Arabia

Title: Cold-active microbial enzymes: In silico approach to understand mechanism and their potential applications

Biography:

Mohammed Kuddus has completed his PhD in Enzyme Biotechnology from India. At present, he is working as a Professor and Chairman of Biochemistry Department at University of Hail, Saudi Arabia. Prof. Kuddus’s main research area includes enzyme and microbial biotechnology. He has published more than 60 research articles in reputed international journals along with 4 books and 15 book chapters; and presented more than 35 abstracts in national/international conference/symposia. He has been serving as an Editorial Board Member and Reviewer of various international reputed journals.

 

Abstract:

Nowadays, cold-active enzymes and their anticipated applications in various industries attracted worldwide attention due to less energy requirement for their optimal activity in comparison to their meso and thermophilic counterparts. Until now, very few cold-active enzymes are known and least explored so far in various industries. In this study, cold-active cellulase from well-studied psychrophilic bacterium Pseudoalteromonas haloplanktis is evaluated for its mecahnism of action and industrial application compared to the normally used mesophilic and thermophilic cellulases by in silico approach. The cellulase structure from different origin subjected to molecular docking studies with the substrate cellulose by using MVD. The binding energy for thermo, meso and psychrophilic cellulase enzymes found to be -93.29, -75.54 and -126.60 KCals/mole, respectively. The results specify that psychrophilic cellulase enzyme from Pseudoalteromonas haloplanktis has more efficiency to bind with cellulose (Figure 1) in comparison to its mesophilic and thermophilic counterparts. The study showed that in silico approach could be used for the screening of different enzymes activity with specific substrate and cold-active cellulase may find better commercial application in food processing industry.

Meetings International -  Conference Keynote Speaker Majid Malaki photo

Majid Malaki

Sevome Shaban Hospital Tehran, Iran

Title: Statins: A Distant Hope, Thousands Dangers in Near

Biography:

Majid Malaki assistant professor Sevome Shaban Hospital Tehran, Iran

Abstract:

We hear daily a lot about statins , a commonly used drug for dyslipedemia, effective on cardiovascular diseases risks,while  most  studies that evaluate statins benefits ignore its side effects they analyse selective age groups of lower 65 and over 30 years and extend their results to all .one of them published In 1995 showed that Statins decrease hazard risk of cardiovascular events when taking regularly for 5 years [1] while 21 years after then it was revealed that in age over 60, LDL-C level is not associated with CVD risk but inversely  can attribute to all-cause mortality [2]Statins have well known side effects and many others have not been described completely such as diabetes mellitus and renal dysfunction that may lead to insidious and fatal acute renal failure following rhabdomyolisis especially after some types of statins such as cerivastain [3,4]. Association of statins with cancer in prolonged use is another side effects that is not proved or rejected until now [5] statins safety is an unknown concept because of different physiologic nature of older and younger people [6]. Statins’s forbidden during pregnancy and breast feeding back to different biologic actions of statins because of cholesterol plays important role in growth and development of younger age, cholesterol is a part of steroid hormones that play role in sexual process metabolisms and bile salts structures , these show safety of a drug in adults should not be addressed to children [7].

Conclusion : statins dangers versus benefits should be individualize always. 

Meetings International -  Conference Keynote Speaker OLANREWAJU BADMUS photo

OLANREWAJU BADMUS

Aqua Research Centre, Jos, Plateau state, Nigeria

Title: Determination of Microbial Load of frozen Smoked Fish Sold in Jos Metropolis Plateau State Nigeria

Biography:

Badmus has MSc degree in Aquaculture and Fisheries. He is currently running is PhD on Fisheries and Aquaculture. He was a former Head of department, Fisheries and Aquaculture at Federal College of Animal Health & Production Technology, Jos, Plateau State, Nigeria. He was a former National Vice President, Fisheries Society of Nigeria (FISON) and pioneer President Nigeria Association of Carp fish Society.  Badmus is a key player and convener for the formation of World Aquaculture Africa Chapter meeting with Fisheries Society of Nigeria. He is a researcher of note.

Abstract:

The present study investigated three different imported frozen fish ( Trichurius, Sardinella mandenrensis, Scomber scombus) collected from three major markets, Bukuru, Terminus and New – Satellite markets to detect bacterial, and fungi contaminants and also microbial load. A total of 270 smoked fish samples were bought from 3 different markets respectively. The data obtained were analyzed using Analysis of Variance. The isolates were characterized using Blood Agar (BA), Eosin Methylene Blue Agar (EMBA), Macconkey agar (MA), and Salmonella/Shigella agar (SSA) media plates after incubation at 370C for 24hrs and growth from plates were subjected to gram staining. The isolates identified were Staphylococcus aureus, Salmonella, Bacillus cereus, Escherichia coli, and Corynebacterium diphtheria. A total of 50% bacterial prevalence rate was observed in the 3 locations. Fungal  load in respect to location shows that 100% were observed at the New – Satellite market shows there is significance difference of fungal contamination at (P<0.005). The highest bacterial load was in Trichurius from Terminus with mean of 32.78+1.94 which shows there is a difference (P<0.05), while the lowest bacterial load with the mean of 13.46+2.90 on Samonella mandanrensis. In respect to bacterial load on fish parts, the highest bacterial load was recorded on the head of Scomber scombus with the mean of 28.93+33.00 significantly at P<0.05,while the lowest bacterial load was recorded on the flesh of Trichurius with the mean of 13.66+2.83. In conclusion, the prevalence rate of each bacterium in the studied fish, Samonella, Streptoccocus, C dipheteria, Bacillus cereus, were 13%, 18.2%, 4.5% respectively.  

Meetings International -  Conference Keynote Speaker Jaleel Kareem Ahmed photo

Jaleel Kareem Ahmed

College of Materials Engineering, Babylon University, Iraq

Title: Using chlorophyll as gamma absorber

Biography:

Jaleel Kareem Ahmed, Polymer and Petrochemical Industries Department, College of Materials Engineering, Babylon University, Babylon, Iraq

Abstract:

Chlorophyll extracted from celery using 50% v/v water – methyl alcohol as a solvent. By this method theconcentration of chlorophyll was 22.6% with yellowish-green color. This solution showed strongly absorption at 400 – 210 nmand maximum was at the end of ultra-violet region. This absorption appeared in water, methyl alcohol, and acetone, butstrongest absorption was in water. No emission spectra was detected in the ultra-violet and visible regions which means thatchlorophyll absorbs radiation and dissipate it as a heat.Several samples of the above solution was radiated by gamma ray fromcesium-137 with energy of 0.7 Mev for different intervals (0.5, 1, 2, 4, 24 hours). The color of the solution disappeared aftertwo hours radiation while the pH decreases from 6.38 for unradiated to radiated celery solution 4.17 after 24 hours radiationwith liberation of carbon dioxide which indicates destroying of chlorophyll but the absorption at 400 – 210 nm still existswhich reflects the high stability of the group magnesium-four nitrogen atoms (tetrapyrrole) its energy about 3500 kJ mol-1. Theresulted carbon dioxide carries by hemoglobin to expel via lungs similar to that produces by biological activity of thebody.Calculation showed that the dosage of two hours radiation in which color of the solution disappeared (Compton effect)was 5.6 killogray (1 gray = 1 Joule per 1 kg sample) absorbed by chlorophyll before color disappear is enough to kills 1120people weight 75 kg each within 14 days when the whole bodies exposure at one time.The samples glass containers and theirwhite plastic covers of the radiated samples for 4 and 24 hours changed their color to violet may be due to the rearrangement oftheir physical structures. Others interesting points will appear in the full article.Capsules used as carrier for the chlorophyll totake it by children.

Keywords: Chlorophyll, Gamma Ray, pH, Celery, Energy

Meetings International -  Conference Keynote Speaker Nazish Nazir photo

Nazish Nazir

University of Kashmir, Srinagar,India

Title: Adventitious rooting in shoot cuttings of Taxus wallichiana Zucc., an endangered medicinally important conifer of Kashmir Himalaya

Biography:

Nazish Nazir, born on 12-05-1988 at Sopore Town of  J&K, India. She has done her B.Sc in 2009 from University of Kashmir, J&K, India with First Division. M.Sc (Botany) in 2011 from Jamia Hamdard University, New Delhi, India and Ph.D (Botany) in 2018 from University of Kashmir, J&K, India. She has no. of publications in reputed national and international journals and also has published a book at international level.

Abstract:

Taxus wallichiana Zucc. (Himalayan yew), is precious for taxol or paclitaxel removal used in the research of anti-cancer drugs (ovarian cancers, AIDS related cancers and other indications). It is a slow growing tree species due to its poor natural regeneration and very low seed germination. The present investigation tested the consequence of different plant growth regulators such as , Indole Butyric Acid (1BA), Indole-3- Acetic Acid (1AA) and Naphthalene Acetic Acid (NAA) on adventitious  rooting  of Himalayan yew shoot cuttings in four different seasons (spring, summer, autumn and winter) under nursery conditions. Shoot cuttings were treated with diverse concentrations of IBA, IAA and NAA. However, IBA at 1000 ppm in spring season (Mar-May) showed best response in stipulations of root length, root number and rooting percentage. The present investigation reveals that this method has the potentiality of using the young shoot cuttings of Himalayan yew in presence of plant growth regulating hormone IBA for its propagation and production on large extent to congregate the increasing stipulate

Meetings International -  Conference Keynote Speaker Pramathadhip Paul photo

Pramathadhip Paul

University of Calcutta, India

Title: Heavy chain antibodies of camelid format as an alternative strategy to prevention, detection and control of allergic diseases

Biography:

Pramathadhip Paul is a Ph.D. senior research fellow at University of Calcutta, Department of Zoology, Immunology and Regenerative Medicine Research Laboratory, India. He has published seven papers in reputed journals.   He will try to convey his ideas with passion and enthusiasm which can help better drug discovery for the lung research.  As a young researcher he would work enthusiastically and refine their approach and it would be a great way to improve his performance for the drug discoveries.

Abstract:

Antibodies are important therapeutic agents which are increasingly used in experimental research and medical applications. Antibody engineering, such as recombinant antibody fragments, have shown high specificity against various antigens.   Nanobodies or VHH are the special types of small proteins composed only of heavy chains from Camelids and represent a new generation of therapeutic immunecytical agents.  Most prominent advantages of VHH over conventional antibodies are their performance at high temperature up to 90ºC, stable folding, long CDR3 regions, and stability under harsh conditions. The purpose of our present research work is to explore, validate and characterize:  i) process (es), and ii) product (s) that could be used to develop diagnostic and therapeutic strategies for inflammatory and degenerative diseases, mainly systemic and tissue specific inflammation and extensive tissue damages and regressive loss of cellular structure. To this effect, novel nano-sized antibodies with a spectrum of convenient biophysical and biochemical properties have been used. Not only have we successfully generated proof-of-concept for the technology platform by simplifying the process of antibody generation in a complex mammalian system via introduction of simple yet powerful bioreactors such as bacteria and viruses, but also, the libraries of antigen specific camelid antibodies – anti α- amylase and anti-ovalbumin specific nanobody  provide a large number of clonal variations that may be modified and used to develop diagnostic kits for simple and non-invasive detection of presence of disease markers in body fluids for effective treatment of the patients.

Meetings International -  Conference Keynote Speaker Ljudmila Stojanovich photo

Ljudmila Stojanovich

University Medical Centre, Belgrade, Serbia

Title: ANTIPHOSPHOLIPID ANTIBODIES: CLINICAL AND DIAGNOSTIC PROBLEM AS AN INTRIGUING NOTIONS ON IMMUNOLOGY

Biography:

Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Full Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles.  She is in Editorial Boards (LUPUS/LONDON), the reviewer in the “CURRENT CONTENSTS” or “Science citation index”, like Cellular and Molecular Neurobiology, and others. She is a member of number International Projects. She was in Invited Speaker for many lectures in Congresses and Symposia; Prof. Stojanovich is EULAR Honorary Member; the Chairman in the International Congress “Antiphospholipid syndrome (Hughes syndrome)”, 2013, co- chairman and the lector “LUPUS ACADEMY EASTERN EUROPEAN ROADSHOW of EULAR”, 2016.

Abstract:

Antiphospholipid syndrome (APS) is defined by clinical manifestations that include thrombosis and/or fetal loss or pregnancy morbidity in patients with antiphospholipid antibodies (aPL). DIAGNOSTIC PROBLEM. Antiphospholipid antibodies are among the most common causes of acquired thrombophilia, but unlike most of the genetic thrombophilias are associated with both venous and arterial thrombosis. Antiphospholipid antibodies are directed primarily toward phospholipid binding proteins rather than phospholipid per se, with the most common antigenic target being β2-glycoprotein 1 (β2GPI) although antibodies against other targets such as prothrombin are well described. Laboratory diagnosis of aPL depends upon the detection of a lupus anticoagulant (LA), which prolongs phospholipid-dependent anticoagulation tests, and/or anticardiolipin and anti-β2-glycoprotein 1 antibodies. Indefinite anticoagulation remains the mainstay of therapy for thrombotic APS, although new strategies that may improve outcomes are emerging. CLINICAL PROBLEM.  While the clinical presentation of APS can be quite diverse because the disease can affect virtually any organ system, patients typically present with symptoms relating to joint, skin or mucosal inflammation, or with a varying degree of haematological abnormality or constitutional features. However, the lack of a gold standard test to confirm diagnosis often results in delays or misdiagnosis. CONCLUSIONS.  Despite updates of the diagnostic criteria, the diagnosis of APS remains difficult. Some aspects of the Sydney criteria were debated after their introduction. Further research on clinically relevant antibodies and standardization of their detection are needed to improve clinical risk assessment in APS.  Funding: This work was supported by research grant number 175041 for 2011 – 2018, and by research grant number TR 32040 for 2011-2018, issued by the Ministry of Science of the Republic of Serbia.

Meetings International -  Conference Keynote Speaker Franca Nneka Alaribe photo

Franca Nneka Alaribe

Tshwane University of Technology Pretoria,South Africa

Title:  A modern approach from traditional use: medicinal plant extracts in scaffolds for tissue engineering and regenerative medicine

Biography:

Franca Nneka Alaribe – PhD in Biomedical Sciences, School of Medicine, University of Ferrara Italy, specializes in cellular/molecular pathology in cancer and degenerative diseases; MSc in Molecular Biology/Biotechnology, Vrije University Brussels Belgium; a postdoctoral fellow at Tshwane University of Technology from 2014 working on stem cells and scaffold fabrication with South African medicinal plants. Dr Alaribe has been a researcher for over 11 years with high competence in biomedical research; has coordinated many research projects for NRF, THRIP, Bone South Africa and OSTA involving biomaterials; published more than 16 research works and academic papers in international peer reviewed journals; editor and board member of several peer reviewed journals and fellow of many scientific organizations.

Abstract:

Bone and cartilage repair continue to be a challenge. Autologous and allografts are the gold standard for the treatment of bone and cartilage. They have invasive, open surgical procedure that requires the tissue to be harvested from alternative site within the patient. Africa is rich in native flora that is currently tapped as medicine by traditional healers. However, little is known about the natural products of our native flora and their potential to serve as remedy for osteoarthritis, bone fracture and wound healing. Our project fabricated medicinal plant extract scaffolds by incorporating natural biopolymers and crude extracts from plants using lyophilization technique.  Subsequently, the scaffold samples were physically characterized and in vitro monitored so as to access osteogenic, chondrogenic, proliferation capacity, anti-inflammatory and bone/cartilage marker expression using different biological, immunological and genetic techniques. Scanning electron microscope (SEM) and EDS revealed that the plant extract scaffolds possess porous structure and organic compounds than in scaffolds without plant extracts. The porcine adipose derived mesenchymal stem cells (pADMSCs) incubated with plant extract scaffolds showed significant differences with regard to proliferation and cell attachment compared to pADMSCs incubated with non-plant extract scaffolds in immunofluorescence analysis. The Eucomis autumnalis crude extract significantly (P < 0.01) suppressed the protein expression of IL-6 in comparison to extracts prepared from Pterocarpus angolensis and untreated groups in ELISA assay. Collagen type II alkaline phosphatase, osteocalcin and osteopontin were significantly expressed in Pterocarpus angolensis group compared to Eucomis autumnalis and other groups in RT-PCR analysis.